Drug Price Control News

Science

Centre to weigh exempting Meril stents from price cap

Meril Life has sought a price exemption for developing unique, biodegradable stentsNPPA meet on Monday is likely to discuss the price exemption claim. If granted, it will be valid for five years

2 min read21 Jan 2019
Politics

No price cap on new patented drugs for five years

The provisions of DPCO 2013 shall not apply to 'drugs for treating orphan diseases as decided by the ministry of health and family welfare', says a government notification

1 min read4 Jan 2019
Industry

Pharma lobby for hiking cost of drugs under govt price control

Rise in prices of APIs after China crackdown on the manufacturers has affected small Indian drug makers

2 min read12 Nov 2018
Companies

Meril may get relief on price cap for its stent

Meril has developed MeRes100, which it claims is the country's first locally made bioresorbable vascular scaffold, or naturally dissolving stent for clearing blockages in arteries

4 min read18 Jul 2018
Industry

Government weighs linking medicine prices to wholesale inflation

NITI Aayog's proposal link drug prices to wholesale inflation is likely to bring down medicine pricesa blow to the pharma industry

3 min read30 May 2018
Industry

India to overhaul drug price control system

The overhaul of the drug pricing policy will be discussed at a meeting on 10 April at the PMO with experts from NITI Aayog, pharma dept, NPPA and the health ministry

1 min read5 Apr 2018
Industry

NPPA fixes retail price of 30 drug formulations

Besides fixing retail price of 30 drug formulations, NPPA has also revised the prices of three formulations, including that of anti cancer drug Gemcitabine

1 min read17 Jan 2018
Industry

Drug associations boycott pharma department’s meeting on drug prices control

Drug lobby groups allege that the Department of Pharmaceuticals is hoodwinking them by giving a very short notice to them to air their opinion on the proposed changes in the Drug Prices Control Order 2013

2 min read1 Nov 2017
Opinion

Pharma confusion

Quality control in the pharma sector is indeed an issue, but focusing on outcomes instead of micromanaging the means would be a better way to address this

1 min read24 Oct 2017
Science

Coronary stents supply and production must be maintained by manufacturers: govt

Following reports of a shortage of coronary stents in hospitals, the government has blocked manufacturers from withdrawing their stents until December

2 min read28 Sep 2017
Load More

Popular Topics

Budget

The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared

25 Articles

infosys

Shares of Infosys were up by 0.43% at closing.

14 Articles
HomeMarketsPremiumFor youGet App